Skip to main content
Premium Trial:

Request an Annual Quote

The Catch-22: To Debate It You Have to Cite It

Michael Eisen has a post at his It Is Not Junk blog taking on a paper from James Evans that suggests that free access to literature has little effect on citations. "This paper ... has many flaws," Eisen writes, proceeding with his list of "the most egregious." For one thing, Eisen says, citation rates aren't the best measure of the value of free access -- and for another, he notes, the raw data haven't been made available for other scientists to perform their own analyses. (Maybe the authors didn't think making their data available would improve their citation rate.)

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.